Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1956 2
1957 1
1964 3
1966 1
1979 2
1981 1
1991 1
1992 1
1993 2
1994 2
1996 1
1997 2
1999 1
2001 3
2002 6
2003 6
2004 4
2005 2
2006 3
2007 3
2010 4
2011 11
2012 6
2013 4
2014 11
2015 2
2016 3
2017 1
2018 1
2019 4
2020 4
2021 5
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
Niveau de preuve du suivi therapeutique pharmacologique de l'atazanavir.
Solas C, Muret P; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Solas C, et al. Among authors: muret p. Therapie. 2011 May-Jun;66(3):213-9. doi: 10.2515/therapie/2011032. Therapie. 2011. PMID: 27393201 French.
Acitretin-associated thrombotic stroke.
Royer B, Ziegler F, Muret P, Davani S, Kantelip JP. Royer B, et al. Among authors: muret p. Ann Pharmacother. 2002 Dec;36(12):1879-82. doi: 10.1345/aph.1C090. Ann Pharmacother. 2002. PMID: 12452748
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
Benaboud S, Solas C, Bouchet S, Gregoire M, Lemaitre F, Venisse N, Lê MP, Muret P, Parant F, Neant N, Boujafaar S, Lagoutte-Renosi J, Garraffo R, Peytavin G. Benaboud S, et al. Among authors: muret p. J Antimicrob Chemother. 2023 Mar 2;78(3):853-854. doi: 10.1093/jac/dkad009. J Antimicrob Chemother. 2023. PMID: 36683308 No abstract available.
Optimum combination therapy regimens for HIV/HCV infection.
Rey D, Muret P, Piroth L. Rey D, et al. Among authors: muret p. Expert Rev Anti Infect Ther. 2016;14(3):299-309. doi: 10.1586/14787210.2016.1147952. Expert Rev Anti Infect Ther. 2016. PMID: 26822803 Review.
[Evidence-based therapeutic drug monitoring for nevirapine].
Muret P, Piedoux S, Solas C, Quaranta S; Groupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Muret P, et al. Therapie. 2011 May-Jun;66(3):187-95. doi: 10.2515/therapie/2011030. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819802 Review. French.
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
Lemaitre F, Lagoutte-Renosi J, Gagnieu MC, Parant F, Venisse N, Grégoire M, Bouchet S, Garraffo R, Lê MP, Muret P, Comets E, Solas C, Peytavin G; ANRS-MIE-BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS-MIE AC43. Lemaitre F, et al. Among authors: muret p. Br J Clin Pharmacol. 2024 Jan;90(1):264-273. doi: 10.1111/bcp.15890. Epub 2023 Sep 18. Br J Clin Pharmacol. 2024. PMID: 37602480 Free article.
103 results